HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effects of pantoprazole on ulcer healing delay associated with NSAID treatment.

Abstract
Nonsteroidal anti-inflammatory drugs delay gastric ulcer healing, and the ability of proton pump inhibitors to counteract this detrimental effect is debated. This study evaluates the effects of pantoprazole on experimental gastric ulcer healing in the presence of indomethacin. Rats with acetic-acid-induced gastric ulcers were orally treated for 3 or 7 days with pantoprazole (15 micromol/kg/day) or famotidine (20 micromol/kg/day), alone or in combination with indomethacin (3 micromol/kg/day). Ulcerated tissues were processed to assess ulcer area, malondialdehyde, proliferating cell nuclear antigen (PCNA) and cleaved caspase-3. Experiments on pylorus-ligated rats indicated that pantoprazole and famotidine were employed at equivalent inhibitory doses on gastric acid secretion (-67.9% and -64.5%, respectively). Indomethacin delayed ulcer healing both at days 3 and 7 (+22 and +35 mm(2) vs control ulcer, respectively). At day 3, pantoprazole was more effective than famotidine in promoting ulcer healing in indomethacin-treated animals (-53.6 and -31.6 mm(2) vs indomethacin, respectively). Malondialdehyde levels and caspase-3 activation in ulcers were increased by indomethacin (+79% and +3.7 folds vs control ulcer, respectively), and these effects were counteracted by pantoprazole (-77.9% and -3.5 folds vs indomethacin, respectively), but not famotidine. Increments of ulcer PCNA expression (+2.5 folds vs normal) were enhanced further by pantoprazole or famotidine, alone or in combination with indomethacin (+8.6 and +10.3 folds vs normal, respectively). Similar results were obtained after 7-day treatments of ulcerated animals with test drugs. It is concluded that, along with acid suppression, pantoprazole exerts acid-independent effects on ulcer healing, which can be ascribed to a decrease in tissue oxidation and apoptosis.
AuthorsMatteo Fornai, Rocchina Colucci, Luca Antonioli, Narcisa Ghisu, Marco Tuccori, Corrado Blandizzi, Mario Del Tacca
JournalNaunyn-Schmiedeberg's archives of pharmacology (Naunyn Schmiedebergs Arch Pharmacol) Vol. 379 Issue 3 Pg. 305-13 (Mar 2009) ISSN: 1432-1912 [Electronic] Germany
PMID18853145 (Publication Type: Journal Article)
Chemical References
  • 2-Pyridinylmethylsulfinylbenzimidazoles
  • Anti-Inflammatory Agents, Non-Steroidal
  • Anti-Ulcer Agents
  • Proliferating Cell Nuclear Antigen
  • Proton Pump Inhibitors
  • Famotidine
  • Pantoprazole
  • Caspase 3
  • Acetic Acid
Topics
  • 2-Pyridinylmethylsulfinylbenzimidazoles (administration & dosage, pharmacology, therapeutic use)
  • Acetic Acid
  • Animals
  • Anti-Inflammatory Agents, Non-Steroidal (administration & dosage, adverse effects)
  • Anti-Ulcer Agents (administration & dosage, pharmacology, therapeutic use)
  • Blotting, Western
  • Caspase 3 (metabolism)
  • Disease Models, Animal
  • Famotidine (administration & dosage, pharmacology, therapeutic use)
  • Gastric Acid (metabolism)
  • Male
  • Oxidative Stress (drug effects)
  • Pantoprazole
  • Proliferating Cell Nuclear Antigen (metabolism)
  • Proton Pump Inhibitors (administration & dosage, pharmacology, therapeutic use)
  • Rats
  • Stomach Ulcer (metabolism, prevention & control)
  • Wound Healing (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: